More articles from Lung cancer

Cancer-related mutations in non-tumoral respiratory epithelium: long-term prognosis.
Roberto Chalela Rengifo, Emanuel Carmona, Albert Sánchez-Font, Víctor Curull, Pedro Rocha, Diana Badenes, Raquel Longarón, Joaquín Gea, Ignacio Sánchez-Guerri, Beatriz Bellosillo

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2201; DOI: 10.1183/13993003.congress-2023.PA2201
Understanding BRAF mutation in non-small cell lung cancer patients
Mariaenrica Tine, Giulia Squarzoni, Davide Ortolan, Federica Pezzuto, Fiorella Calabrese, Giulia Squarzoni

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2210; DOI: 10.1183/13993003.congress-2023.PA2210
Prognostic impact of reactive oxygen species modulator 1 (Romo1) in resected EGFR-mutant lung adenocarcinoma
Tae Woo Kim, Myung Jae Park, Seung Hyeun Lee

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2202; DOI: 10.1183/13993003.congress-2023.PA2202
Machine Learning Predicts metastasis of cT1 solid lung cancer
Jing Huang, Jie Lan, Weiyi Li, Junhao Mu, Min Ao, Longke Ran, Li Yang

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2217; DOI: 10.1183/13993003.congress-2023.PA2217
Comparative analysis according to alpha-1 Antitrypsin genotype in a cohort of patients with lung cancer in Northwest Spain
Ramon Antonio Tubio Perez, Esmeralda Garcia Rodriguez, Ana Priegue Carrera, María Torres Durán, Carlos Vilariño Pombo, Raquel Dacal Quintas, Isaura Parente Lamelas, Raquel Barbosa Lorenzo, Alberto Fernandez Villar

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2215; DOI: 10.1183/13993003.congress-2023.PA2215
Spread through air spaces prognostic value in adenocarcinoma
Mara Daniela Silva Sousa, Mariana Gonzalez Ribeiro, Catarina Sousa, Hélder Novais-Bastos, David Araújo, Gabriela Fernandes, Adriana Magalhães, André Carvalho, Susana Guimarães, Conceição Souto Moura, Venceslau Hespanhol, Cláudia Freitas

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2214; DOI: 10.1183/13993003.congress-2023.PA2214
Late Breaking Abstract - Higher radiation dose in chemoradiotherapy followed by immunotherapy with durvalumab in patients with stage III non-small cell lung cancer does not increase risk for pneumonitis.
Felix Schragel, Melanie Matousek, Christoph Resl, Peter Errhalt, Klaus Hackner

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2209; DOI: 10.1183/13993003.congress-2023.PA2209
Sphingolipid metabolism in the pathogenesis of advanced non-small cell lung cancer
Lilla Büdi, Dániel Hammer, Rita Varga, Veronika Müller, Ádám Domonkos Tárnoki, Dávid László Tárnoki, Martina Mészáros, András Bikov, Péter Horváth

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2207; DOI: 10.1183/13993003.congress-2023.PA2207
Next-generation sequencing in stage l-lll vs stage lV non-small cell lung cancer
Miguel Trigueiro Rocha Barbosa, Joana Ribeiro, Raquel Paulinetti, Telma Sequeira, Paulo Mota, Cristina Albuquerque, Teresa Almodovar

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2211; DOI: 10.1183/13993003.congress-2023.PA2211
Changes of lung microbiota composition in patients with non-small cell lung cancer
Vytautas Ankudavicius, Darja Nikitina, Rokas Lukosevicius, Jurgita Skieceviciene, Juozas Kupcinskas, Skaidrius Miliauskas, Marius Zemaitis

European Respiratory Journal Sep 2023, 62 (suppl 67) PA2206; DOI: 10.1183/13993003.congress-2023.PA2206

Main menu

User menu

Search

More articles from Lung cancer

Pages

Contact us